Wren Capital: Funding, Team & Investors | Startup Intros

Loading organizations...

Wren Capital: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Dec 18, 2023	MitoRx Therapeutics	$5.1M Seed	—	Fink Family Office, Longevity Tech Fund, Oxford Technology Management, Science Angel Syndicate, Oliver Sexton
Dec 1, 2023	Spotta	$4.0M Series A	Timothy Mills, STIHL Digital, The Yield Lab	ACF Investors, Rianta Capital, Cambridge Angels, Cambridge Capital Group, GrowthWorks, Martlet Capital, Remus Capital
May 1, 2023	PharmEnable	$7.0M Seed	Jeffrey Moore	MP Healthcare Venture Management, Damien Lane, Jonathan Milner, Arrowfield Capital, Keith Blundy, Heyford Trust, Martlet Capital, o2h Ventures, Parkwalk Advisors, University of Cambridge
Feb 1, 2022	Centauri Therapeutics	$33.0M Series A	—	Boehringer Ingelheim Venture Fund, Animatrix Capital, Johannes Zanzinger, Karen Lackey, Kent Life Science, Camilla Petrycer Hansen
Nov 2, 2021	Tay Therapeutics	$2.2M Pre-Series A	Sunil Shah	Meltwind, Kerry Sharp, Anne Muir
Mar 23, 2021	Adapttech	$2.8M Other Equity	—	ACF Investors, Bionova Capital, Mercia, Wealth Club
Jul 1, 2020	Spotta	$1.0M Seed	—	ACF Investors, REMUS Capital, Rianta Capital, Salesforce Ventures, Timothy Mills, Paul Anson, Martlet Capital, Rajat Malhotra
Jun 29, 2020	PharmEnable	$2.2M Seed	Christine Martin, University of Cambridge	Andrew J M Richards, David Ford, Ian Tomlinson, Jonathan Milner, KQ Labs, Peter McPartland, o2h Ventures
Jun 1, 2014	DefiniGEN	$4.0M Series A	24Haymarket, Cambridge Enterprise	Jonathan Milner, Cambridge Capital Group, Providence Investment Company, Ranworth Capital